Priyanka Kanth

Priyanka Kanth, MSCI, FACG, AGAF, MD

Languages spoken: English, Hindi

Academic Information

Departments Adjunct - Internal Medicine

Divisions: Gastroenterology

Board Certification

  • American Board of Internal Medicine (Sub: Gastroenterology)
  • American Board of Internal Medicine

Dr. Priyanka Kanth received her Medical Degree from Kasturba Medical College in India. She obtained graduate training in Internal Medicine from St. Mary’s Hospital in the United Kingdom and the University of Connecticut in the United States. Dr. Kanth completed her fellowship in the specialty of Gastroenterology at the University of Utah, after which she joined the faculty as an Assistant Professor of Medicine.

Dr. Kanth specializes in the treatment, diagnosis, and continuing care of patients with esophageal disease, general gastrointestinal disorders and hereditary gastrointestinal cancer syndromes. Her research interests include the study of colon polyps, sessile serrated colon polyps, colon cancer prevention and high-risk familial gastrointestinal cancer. Dr. Kanth has received research and travel grants in support of her research work and has been published in peer-reviewed medical journals.

Education History

Professional Medical Kasturba Medical College, Manipal Academy of Higher Education (MAHE) University
 MD
Internship Kasturba Medical College/Heavy Engineering Corporation Hospital
 Intern
Residency Primary Health Center
 Senior House Officer
Research Fellow All India Institute of Medical Sciences (AIIMS)
 Senior Research Fellow
Residency Royal Albert Edward Infirmary, Wigan and Leigh Trust
 Resident
Residency St. Mary's Hospital, Isle of Wight Healthcare NHS Trust
 Resident
Residency University of Connecticut Health Center
 Resident
Chief Resident University of Connecticut Health Center
 Chief Medical Resident
Fellowship University of Utah Health Center
 Fellow
Graduate Training University of Utah
 MSCI

Selected Publications

Journal Article

  1. Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ (2017). Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol, 112(10), 1509-1525. (Read full article)
  2. Kanth P, Yu Z, Keener MB, Koptiuch C, Kohlmann WK, Neklason DW, Westover M, Curtin K (2021). Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. Am J Gastroenterol.
  3. Chang K, Willis JA, Reumers J, Taggart MW, San Lucas FA, Thirumurthi S, Kanth P, Delker DA, Hagedorn CH, Lynch PM, Ellis LM, Hawk ET, Scheet PA, Kopetz S, Arts J, Guinney J, Dienstmann R, Vilar E (2018). Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Ann Oncol, 29(10), 2061-2067. (Read full article)
  4. Kanth P, Hazel MW, Boucher KM, Yang Z, Wang L, Bronner MP, Boylan KE, Burt RW, Westover M, Neklason DW, Delker DA (2018). Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer. Genes Chromosomes Cancer, 58(1), 23-33. (Read full article)
  5. Kanth P, Inadomi JM (2021). Screening and prevention of colorectal cancer. BMJ, 374, n1855. (Read full article)
  6. Jasperson KW, Kanth P, Kirchhoff AC, Huismann D, Gammon A, Kohlmann W, Burt RW, Samadder NJ (2013). Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum, 56(11), 1211-6. (Read full article)
  7. Kanth P, Go MF (2011). Squamous papilloma: an unusual esophageal entity. Endoscopy, 43 Suppl 2 UCTN, E405-6. (Read full article)
  8. Ashktorab H, Delker D, Kanth P, Goel A, Carethers JM, Brim H (2019). Molecular Characterization of Sessile Serrated Adenoma/Polyps From a Large African American Cohort. Gastroenterology, 157(2), 572-574. (Read full article)
  9. Ochs-Balcom HM, Kanth P, Farnham JM, Abdelrahman S, Cannon-Albright LA (2020). Colorectal cancer risk based on extended family history and body mass index. Genet Epidemiol, 44(7), 778-784. (Read full article)
  10. Reyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuelta M, Chang K, You YN, Kopelovich L, Wistuba II, Lee JJ, Sei S, Shoemaker RH, Szabo E, Richmond E, Umar A, Perloff M, Brown PH, Lipkin SM, Vilar E (2021). Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Gut, 70(3), 555-566. (Read full article)
  11. Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada S (2016). Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. JAMA, 315(12), 1266-75. (Read full article)
  12. Burke CA, Dekker E, Lynch P, Samadder NJ, Balaguer F, Hüneburg R, Burn J, Castells A, Gallinger S, Lim R, Stoffel EM, Gupta S, Henderson A, Kallenberg FG, Kanth P, Roos VH, Ginsberg GG, Sinicrope FA, Strassburg CP, Van Cutsem E, Church J, Lalloo F, Willingham FF, Wise PE, Grady WM, Ford M, Weiss JM, Gryfe R, Rustgi AK, Syngal S, Cohen (2020). Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. The New England journal of medicine, 383(11), 1028-1039. (Read full article)
  13. Caliskan A, Kohlmann WK, Affolter KE, Downs-Kelly E, Kanth P, Bronner M (2018). Intramucosal lipomas of the colon implicate Cowden syndrome. Modern pathology, 31(4), 643-651. (Read full article)
  14. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter J (2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nature cell biology,
  15. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter (2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nature cell biology, 19(9), 1027-1036. (Read full article)
  16. Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason D (2018). Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC gastroenterology, 18(1), 115. (Read full article)
  17. Kanth P, Tendler B, Forouhar (2008). A case of thyroid storm with underlying thyroid carcinoma. The Endocrinologist, 18(2), 62-84.
  18. Kanth P, Fang (2012). Cerebral air embolism: a complication of a bleeding atrioesophageal fistula. Clinical gastroenterology and hepatology, 10(3), A22. (Read full article)
  19. Kanth P, Affolter (2018). Worming Your Way Through the Gastrointestinal Tract: A Case of Strongyloidiasis. Clinical gastroenterology and hepatology, 16(7), A33. (Read full article)
  20. Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP Jr, Hampel H, CGC., Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J, CGC., Peter S, Regenbogen SE, Dwyer MA, CGC., Ogba (2019). NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019. Journal of the National Comprehensive Cancer Network, 17(9), 1032-1041. (Read full article)
  21. Provenzale D, Ness RM, Llor X, Weiss JM, Abbadessa B, Cooper G, Early DS, Friedman M, Giardiello FM, Glaser K, Gurudu S, Halverson AL, Issaka R, Jain R, Kanth P, Kidambi T, Lazenby AJ, Maguire L, Markowitz AJ, May FP, Mayer RJ, Mehta S, Patel S, Peter S, Stanich PP, Terdiman J, Keller J, Dwyer MA, Ogba (2020). NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020. Journal of the National Comprehensive Cancer Network, 18(10), 1312-1320. (Read full article)
  22. Weiss JM, Gupta S, Burke CA, Axell L, Chen LM, Chung DC, Clayback KM, Dallas S, Felder S, Gbolahan O, Giardiello FM, Grady W, Hall MJ, Hampel H, Hodan R, Idos G, Kanth P, Katona B, Lamps L, Llor X, Lynch PM, Markowitz AJ, Pirzadeh-Miller S, Samadder NJ, Shibata D, Swanson BJ, Szymaniak BM, Wiesner GL, Wolf A, Yurgelun MB, Zakhour M, Darlow SD, Dwyer MA, Campbell (2021). NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. Journal of the National Comprehensive Cancer Network, 19(10), 1122-1132.
  23. Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn C (2014). RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PloS one, 9(2), e88367. (Read full article)
  24. Kanth P, Bronner MP, Boucher KM, Burt RW, Neklason DW, Hagedorn CH, Delker D (2016). Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype. Cancer prevention research (Philadelphia, Pa.), 9(6), 456-65. (Read full article)
  25. Delker DA, Wood AC, Snow AK, Samadder NJ, Samowitz WS, Affolter KE, Boucher KM, Pappas LM, Stijleman IJ, Kanth P, Byrne KR, Burt RW, Bernard PS, Neklason D (2018). Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer prevention research (Philadelphia, Pa.), 11(1), 4-15. (Read full article)
  26. Ochs-Balcom HM, Kanth P, Cannon-Albright L (2021). Early-onset colorectal cancer risk extends to second- and third-degree relatives. Cancer epidemiology, 73, 101973. (Read full article)
  27. Kanth P, Boylan KE, Bronner MP, Boucher KM, Hazel MW, Yao R, Pop S, Bernard PS, Delker D (2019). Molecular Biomarkers of Sessile Serrated Adenoma/Polyps. Clinical and translational gastroenterology, 10(12), e00104. (Read full article)
  28. Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason D (2018). Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial. JAMA oncology, 4(5), 671-677. (Read full article)
  29. Kanth P, Yu Z, Keener MB, Koptiuch C, Kohlmann WK, Neklason DW, Westover M, Curtin (2021). Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. The American journal of gastroenterology, 117(2), 336-342. (Read full article)
  30. Kanth P, Yu Z, Keener MB, Koptiuch C, Kohlmann WK, Neklason DW, Westover M, Curtin (2021). Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. The American journal of gastroenterology, 117(2), 336-342. (Read full article)
  31. Weiss JM, Gupta S, Burke CA, Axell L, Chen LM, Chung DC, Clayback KM, Dallas S, Felder S, Gbolahan O, Giardiello FM, Grady W, Hall MJ, Hampel H, Hodan R, Idos G, Kanth P, Katona B, Lamps L, Llor X, Lynch PM, Markowitz AJ, Pirzadeh-Miller S, Samadder NJ, Shibata D, Swanson BJ, Szymaniak BM, Wiesner GL, Wolf A, Yurgelun MB, Zakhour M, Darlow SD, Dwyer MA, Campbell (2021). NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. Journal of the National Comprehensive Cancer Network, 19(10), 1122-1132. (Read full article)

Review

  1. Lindsey Bierle, Priyanka Kant (2020). Advanced Imaging in Hereditary Colon Cancer Syndromes. Practical gastroenterology, XLIV(1), 26-36.

Conference Proceedings

  1. Delker DA, Kanth P, et al (May 2013). Next Generation Sequencing Analysis of 5' Capped RNAs Identifires Novel Differentially Expressed Genes in Sessile Serrated Colon Polyps. Gastroenterology, Orlando, FL: Digestive Disease Week, 144(5), S-526.
  2. Kanth P, Hegde P, Rajan TV (2009). Inter-observer variability in re-evaluation of a diagnosis of "Hyperplastic polyp". Gastroenterology, Chicago, IL: Digestive Disease Week, 136(5), A-768.
  3. Kanth P, Peterson K, Boynton K (2012). More Bumps in the Road for IBD: Prevalence and risk factors for sporadic polyps in an IBD cohort. Gastroenterology, San Diego: Digestive Disease Week, 142(3), S-635-S-636.
  4. Kanth P, Bronner M, et a (2016). Small Non-coding RNA Transcriptome in Sessile Serrated Colon Polyps.
  5. Kanth P, Wilkinson L, Levine J, Sanders M, Rajan T (2008). Re­evaluation of diagnosis of 'benign' colon polyp.
  6. Kanth P, Huang T, Tian J, Nagar A (2008). Patients with diabetes mellitus, elevated cholesterol and increased BMI while on medications do not have an increased risk of Colorectal Adenoma.
  7. Kanth P, Thumar J, et al (2008). Cytomegalovirus colitis in an immune­competent patient: Review of Endoscopy findings.
  8. Kanth P, Thumar (2007). Transverse colon diverticulitis: Literature review.
  9. Kanth P, Rajan T (2011). Chromogranin A and Ki67 expression in Normal Colon, Serrated Polyps and Colorectal Tubular Adenomas.
  10. Kanth P, Stayner JL, Samadder N (2012). Cytotoxic T-lymphocyte-Associated Antigen 4 antibody (lpilimumab) associated Enterocolitis.
  11. Kanth P , et a (2016). Use of a Hereditary Cancer Risk Assessment Tool for Patients Undergoing Upper Endoscopy and Colonoscopy: A Quality Improvement Project from a Large Tertiary Care Center (Presidential poster winner).

Editorial

  1. Kanth P, Samadder NJ, DiSario J (2017). Duodenal adenomas in sporadic and familial adenomatous polyposis patients: Birds of a feather? Gastrointest Endosc, 85(4), 813-815. (Read full article)

Abstract

  1. Kanth P, Bronner MP, Boucher KM, Burt R, Neklason DW, Hagedorn CH, Delker DA. (2015). RNA sequencing identifies unique and commonly expressed genes in sessile serrated and hyperplastic colon polyps and demonstrates molecular overlap between syndromic and sporadic sessile serrated polyps [Abstract]. Gastroenterology, 148(4), S-363.
  2. Kanth P, Boylan K et al (2017). Evaluation of a gene expression panel for diagnosis of sessile serrated adenoma/polyps: Report from a large tertiary health care system. [Abstract]. Gastroenterology, 152(5), S539-540.